MARKETS / NASDAQ / NNOX
NASDAQ · X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS · MID CAP

Nano-x Imaging Ltd. NNOX

8 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$13.0M
▲ 15.4% vs FY2024
EPS · FY25
$-1.16
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-45.6%
Net margin · FY25
-576.1%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 13.0M
Revenue, FY2025 · full 8-year series below
Revenue Net income
0.0040.0080.0120.0160.0-0.12018202120242025
0.0040.0080.0120.0160.0-0.12018202120242025

The company lost 576 cents on every revenue dollar this year.

Per share
USD -1.16
Diluted EPS, FY2025
EPS
0.40.81.2-1.162018202120242025
0.40.81.2-1.162018202120242025

The company pays no cash dividend.

Profitability
-45.6%
Return on equity, FY2025
ROE
0.250.50.751-45.6%2018202120242025
0.250.50.751-45.6%2018202120242025
Operating margin-600.8%
Net margin-576.1%
Return on assets-40.3%

Each USD of equity lost 46 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+14.9%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
Shares outstanding, FY2025
0.030.062018202120242025
0.030.062018202120242025
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 162.2M
total assets, end of FY2025
Total assetsUSD 162.2M
EquityUSD 139.7M
CashUSD 49.2M
Gross debtUSD 3.1M
Net debtUSD -46.0M
Current ratio3.96×

The company holds more cash than debt.

History
8 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
Revenue $B
0.0
0.0
0.0
0.0
0.0
·
·
·
Operating income $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
EBITDA $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
Income tax $B
−0.0
−0.0
−0.0
−0.0
−0.0
·
·
·
Net income $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.0
−0.0
EPS, diluted $
−1.16
−0.91
−1.08
−2.17
−1.28
−1.23
−0.90
−0.09
Dividend / sh $
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
ROE %
−45.6
−27.8
−29.5
−44.5
−23.6
−39.5
·
·
Shares out B
·
·
0.06
0.06
0.05
0.05
0.03
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
27 of 27
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed